Previous evidence supports that upregulated CCL4 could be considered to be a circulating inflammatory cytokine marker in primary and systemic lupus erythematosus (SLE)-related autoimmune hemolytic anemia, indicating erythroid compensation and disease severity due to its positive relationship with reticulocyte count (38). This evidence concerns the gene CCL4 and systemic lupus erythematosus.